Analysis of Medicare Part D formulary composition since program inception suggests beneficiaries may not be using their open-enrollment periods to reevaluate available plan offerings.
Kirsten J. Axelsen, MS
Advertisement
Articles by Kirsten J. Axelsen, MS
Advertisement
Latest Updated Articles
- Racial Differences in Switching, Augmentation, and Titration of Lipid-lowering Agents by Medicare/Medicaid Dual-eligible Patients
Published: June 1st 2007 | Updated:
- Medicare Part D Formulary Coverage Since Program Inception: Are Beneficiaries Choosing Wisely?
Published: November 15th 2008 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research COuld Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs
4
Value-Based Care Interventions and Management of CKD Progression
5
